Quest Diagnostics Inc.

Products

Category

Product

Brand

Description

Global Prenatal Testing Market (MDS103A)

QNatal Advanced		QNatal Advanced is a cell-free DNA test screening for fetal chromosomal abnormalities (e.g., trisomy 21, trisomy 18, trisomy 13) and sex chromosome abnormalities. It can also screen for certain microdeletions and fetal sex, but it does not assess the risk of neural tube defects or ventral wall defects.
QHerit carrier screening		Herit, QHerit Plus, QHerit Extended, QHerit 421 and QHerit 381 are carrier “screening” tests. They screen for gene variations linked to certain health disorders that can be passed from parents to children. QHerit screens 24 genes; QHerit Plus screens 85 genes; QHerit Extended screens 150 genes; QHerit 421 screens 421 genes; and QHerit 381 screens 381 genes.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment